1.A Systematic Comparative Evaluation of ⁶⁸Ga-Labeled RGD Peptides Conjugated with Different Chelators
Akanksha JAIN ; Sudipta CHAKRABORTY ; H D SARMA ; Ashutosh DASH
Nuclear Medicine and Molecular Imaging 2018;52(2):125-134
PURPOSE: The present paper reports a systematic study on the effect of bifunctional chelators (BFC) namely, NOTA, DOTA, and DTPA, on the radiochemical formulation, in vitro stability, and in vivo biological properties of ⁶⁸Ga-labeled RGD peptide derivatives.METHODS: The three RGD conjugates namely, NOTA-Bn-E-[c(RGDfk)]₂, DOTA-Bn-E-[c(RGDfk)]₂, and DTPA-Bn-E-[c(RGDfk)]₂ were radiolabeled with ⁶⁸Ga and the radiolabeling was optimized with respect to the ligand amount, radiolabeling time, and temperature. Further, the ⁶⁸Ga complexes were assessed for their in vitro and in vivo stabilities. The biodistribution studies of the three radiolabeled conjugates were carried out in C57BL/6 mice bearing melanoma tumor at 30 min and 1 h post-adimistration.RESULTS: NOTA-Bn-E-[c(RGDfk)]₂ could be radiolabeled with ⁶⁸Ga at room temperature while DOTA-Bn-E-[c(RGDfk)]₂ and DTPA-Bn-E-[c(RGDfk)]₂ were radiolabeled at high temperature. ⁶⁸Ga-NOTA-Bn-E-[c(RGDfk)]₂ was found to be the most kinetically rigid in in vitro stability assay. The uptake of the three radiolabeled peptide conjugates in melanoma tumor was comparable at 1 h post-administration (NOTA; DOTA; DTPA (% I.D./g):: 2.78 ± 0.38; 3.08 ± 1.1; 3.36 ± 0.49). However, the tumor/background ratio of ⁶⁸Ga-NOTA-Bn-E-[c(RGDfk)]₂ was the best amongst the three radiotracers. ⁶⁸Ga-complexes of NOTA-Bn-E-[c(RGDfk)]₂ and DOTABn-E-[c(RGDfk)]₂ showed excellent in vivo stability while ⁶⁸Ga-DTPA-Bn-E-[c(RGDfk)]₂ showed significant metabolic degradation.CONCLUSION: These studies show that ⁶⁸Ga-NOTA-Bn-E-[c(RGDfk)]₂ would be the most appropriate ⁶⁸Ga-labeled radiotracer and the most amenable for kit formulation.
Animals
;
Chelating Agents
;
In Vitro Techniques
;
Melanoma
;
Mice
;
Pentetic Acid
;
Peptides
2.A Systematic Comparative Evaluation of â¶â¸Ga-Labeled RGD Peptides Conjugated with Different Chelators
Akanksha JAIN ; Sudipta CHAKRABORTY ; H D SARMA ; Ashutosh DASH
Nuclear Medicine and Molecular Imaging 2018;52(2):125-134
PURPOSE:
The present paper reports a systematic study on the effect of bifunctional chelators (BFC) namely, NOTA, DOTA, and DTPA, on the radiochemical formulation, in vitro stability, and in vivo biological properties of â¶â¸Ga-labeled RGD peptide derivatives.
METHODS:
The three RGD conjugates namely, NOTA-Bn-E-[c(RGDfk)]â‚‚, DOTA-Bn-E-[c(RGDfk)]â‚‚, and DTPA-Bn-E-[c(RGDfk)]â‚‚ were radiolabeled with â¶â¸Ga and the radiolabeling was optimized with respect to the ligand amount, radiolabeling time, and temperature. Further, the â¶â¸Ga complexes were assessed for their in vitro and in vivo stabilities. The biodistribution studies of the three radiolabeled conjugates were carried out in C57BL/6 mice bearing melanoma tumor at 30 min and 1 h post-adimistration.
RESULTS:
NOTA-Bn-E-[c(RGDfk)]â‚‚ could be radiolabeled with â¶â¸Ga at room temperature while DOTA-Bn-E-[c(RGDfk)]â‚‚ and DTPA-Bn-E-[c(RGDfk)]â‚‚ were radiolabeled at high temperature. â¶â¸Ga-NOTA-Bn-E-[c(RGDfk)]â‚‚ was found to be the most kinetically rigid in in vitro stability assay. The uptake of the three radiolabeled peptide conjugates in melanoma tumor was comparable at 1 h post-administration (NOTA; DOTA; DTPA (% I.D./g):: 2.78 ± 0.38; 3.08 ± 1.1; 3.36 ± 0.49). However, the tumor/background ratio of â¶â¸Ga-NOTA-Bn-E-[c(RGDfk)]â‚‚ was the best amongst the three radiotracers. â¶â¸Ga-complexes of NOTA-Bn-E-[c(RGDfk)]â‚‚ and DOTABn-E-[c(RGDfk)]â‚‚ showed excellent in vivo stability while â¶â¸Ga-DTPA-Bn-E-[c(RGDfk)]â‚‚ showed significant metabolic degradation.
CONCLUSION
These studies show that â¶â¸Ga-NOTA-Bn-E-[c(RGDfk)]â‚‚ would be the most appropriate â¶â¸Ga-labeled radiotracer and the most amenable for kit formulation.
3.Acceleration of cutaneous wound healing by Lucilia sericata maggots in diabetic Wistar rats
Borkataki, S. ; Katoch, R. ; Goswami, P. ; Bhat, A. ; Chakraborty, D.
Tropical Biomedicine 2021;38(No.1):86-93
The study was aimed to evaluate the effectiveness of maggot therapy in healing of cutaneous
infected wound in streptozotocin (STZ) induced diabetic Wistar rat. For live maggots, the
sterilized eggs of Lucilia sericata were obtained from colonies established in laboratory.
Diabetes model was established in 48 male Wister rat by intra-peritoneal injection of STZ
at the dose of 60 mg/kg body-weight. Cutaneous wounds exposed with mixed colonies of
bacteria like Staphylococcus aureus, E. coli and Pseudomonas aeruginosa were prepared in all rat.
The animals equally divided in 4 groups with 12 rats each being presented as treatment
group of control, antibiotic, maggot and maggot with antibiotic in combination. All treatments
were done once and hold for 24 hours. Wound kinetics and bacterial bio burden were
measured at weekly interval to till complete healing. Significant reduction in wound area
with maximum contraction was found (>95%) in maggot treated group when compared to
antibiotic treated (79%) and control (72%). In maggot as well as maggot and antibiotic in
combination group showed early elimination of bacterial bio-burden 7.88±0.03log CFU/ml
to 1.12±0.65log CFU/ml and 7.86±0.04) log CFU/ml to 1.54±0.52log CFU/ml respectively in
three weeks of time. Early healing indication was also experienced on histomorphological
examination of wounded tissue of maggot treated groups by early and better
epithelialization, collagenation and neovascularization with complete healing of wound in
three weeks in comparison to antibiotic and control respectively. However, the present study
did not show any difference in healing of wound with use of maggot alone or in antibiotic
combination. Live maggot of Lucilia sericata effectively lower bacterial bioburden and and
accelerate healing of infected cutaneous wound in diabetic conditions.
4.Therapeutic use of Lucilia sericata maggot in controlling bacterial bio-burden in Rat wound model
Borkataki, S ; Katoch, R ; Goswami, P ; Bhat, A. ; Bhardwaj, H.R ; Chakraborty, D ; Chandrawathani, P
Tropical Biomedicine 2018;35(3):627-638
Delayed wound healing due to extraneous bacterial contamination, antibacterial resistance and other associated factors are of great concern in dealing patients having chronically infected wound. Medicinal properties of certain maggots of Calliphoridae family are known for its effective wound debridement therapy. The objective of the study was to evaluate the wound healing potential of maggots of Lucilia sericata in an experimentally infected cutaneous wound model in Wistar rat. The study was carried out by using male Wistar rats (n=48) by creating excisional wounds and later contaminated with mixed population of gram positive and gram-negative bacteria. Animals were divided randomly in to four groups with 12 individuals each, being denominated as control, antibiotic treated, maggot treated, and antibiotic plus maggot combination treated group. Ten pre-sterilized maggots were applied per centimetre square wound bed for 24 hours. Different wound kinetics in L. sericata maggot treated wounds revealed significant reduction in wound area with maximum contraction, early elimination of bacterial bioburden as compared to group of infected control and group of rats receiving only antibiotic treatment. The histopathological examination of wounded tissue of maggot treated groups showed early and better epithelialization, collagenation and neovascularization with complete healing of wound in two weeks. The maggot effects on healing when used singly or in combination with antibiotic were recorded to be similar. The results of the present study clearly demonstrate that the maggots of L. sericata possesses a definite antibacterial action along with removal of dead tissues and effectively reduced the bacterial bio-burden in infected wound and induced wound healing quickly.